➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for SCY-078

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug SCY-078?

SCY-078 is an investigational drug.

There have been 13 clinical trials for SCY-078. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2017.

The most common disease conditions in clinical trials are Candidiasis, Candidiasis, Vulvovaginal, and Mycoses. The leading clinical trial sponsors are Scynexis, Inc., Clinical Network Services (CNS) Pty Ltd, and Inncelerex.

There are two US patents protecting this investigational drug and fourteen international patents.

Recent Clinical Trials for SCY-078
ADME Study of [14C]-Ibrexafungerp in Healthy Male SubjectsInncelerexPhase 1
ADME Study of [14C]-Ibrexafungerp in Healthy Male SubjectsScynexis, Inc.Phase 1
Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy SubjectsClinical Network Services (CNS) Pty LtdPhase 1

See all SCY-078 clinical trials

Clinical Trial Summary for SCY-078

Top disease conditions for SCY-078
Top clinical trial sponsors for SCY-078

See all SCY-078 clinical trials

US Patents for SCY-078

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SCY-078   Try Before You Buy Salts and polymorphs of SCY-078 SCYNEXIS, INC. (Jersey City, NJ)   Try Before You Buy
SCY-078   Try Before You Buy Antifungal agents Merck Sharp & Dohme Corp. (Rahway, NC) Seynexis, Inc. (Research Triangle Park, NC)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for SCY-078

Drugname Country Document Number Estimated Expiration Related US Patent
SCY-078 Eurasian Patent Organization EA036874 2035-01-19   Try Before You Buy
SCY-078 Eurasian Patent Organization EA201791645 2035-01-19   Try Before You Buy
SCY-078 European Patent Office EP3247711 2035-01-19   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.